Delayed pressure urticaria

J Allergy Clin Immunol. 1982 Nov;70(5):337-42. doi: 10.1016/0091-6749(82)90022-7.

Abstract

Delayed pressure urticaria (DPU) is a poorly understood syndrome. We describe 17 patients with DPU. Chronic urticaria was present in 94%. All had negative challenges for immediate demographism and cold urticaria. DPU was induced with a pressure challenge on the shoulder of 15 pounds for 15 min. Average onset of pressure lesions after challenge was 6.5. Lesions were painful, not pruritic, peaked at 9 hr, and disappeared by 24 to 48 hr. Fever, chills, and/or arthralgias occurred in 78%. Positive laboratory abnormalities included leukocytosis in 20% and elevated erythrocyte sedimentation rate in 37.5%. Skin biopsies of lesions showed perivascular round cell infiltrates and negative immunofluorescence. Urticaria responded to antihistamines, but not aspirin, in 100% of patients, while pressure lesions improved with nonsteroidal anti-inflammatory drugs (NSAID), but not antihistamines, in 80% of patients. Both urticaria and DPU were controlled with prednisone, which was necessary in 87.5% of patients. A severe nonremitting course was noted in 7%, 40% had a moderate remitting course requiring intermittent prednisone, and 53% had a mild remitting disease requiring no medication or antihistamines and/or NSAID only. We conclude that DPU is more common than previously appreciated and likely involves mediators other than histamine, possibly the prostaglandin system.

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Antinuclear / analysis
  • Blood Sedimentation
  • Female
  • Histamine H1 Antagonists / therapeutic use
  • Humans
  • Leukocytosis / etiology
  • Male
  • Prednisone / therapeutic use
  • Pressure / adverse effects
  • Time Factors
  • Urticaria / drug therapy
  • Urticaria / etiology*
  • Urticaria / immunology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Antinuclear
  • Histamine H1 Antagonists
  • Prednisone